Document Type : Original Article

Authors

1 Federal University Otuoke, Bayelsa state, Nigeria

2 Federal University Wukari, Taraba state, Nigeria

Abstract

Malaria and hepatitis C virus (HCV) infections are significant public health challenges when they overlap geographic distributions. There is potential for co-infections and syndemism of both pathogens due to the rising incidence of the overlap between regions endemic for hepatitis C virus and malaria. Hence, the aim of this study was to determine the sero-prevalence of Hepatitis C virus (HCV) and malaria co-infection among outpatients attending General Hospital Wukari, Taraba State, Nigeria. A total of 100 outpatients consisting of 30 males and 70 females within the age of 11 to 70 years were randomly recruited to the study. Rapid diagnostic test kits were used to screen for HCV and malaria among the outpatients. Of the 100 outpatients screened, 12 (12%) were sero-positive for HCV while 4(4%) were sero-positive for Malaria. Of the 12 HCV sero-positive patients, 4 (13.33%) were male while 8 (11.43%) were females. Furthermore, all malaria sero-positive patients were male. Likewise, malaria and HCV co-infection in this study was 2%. Although low, the prevalence of HCV infection, malaria and HCV-malaria co-infection are worrisome especially in this area. Hence, patients should be encouraged to go for routine screening and know their infection status so as to prevent complications due to active infection.

Graphical Abstract

Unveiling Co-Infections: Hepatitis C Virus And Malaria Sero-Prevalence Among Outpatients Attending General Hospital Wukari In Taraba State, Nigeria

Keywords

Main Subjects

OPEN ACCESS

©2024 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

 

 

  1. Phelan M, Cook C. A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients. BMC infectious diseases. 2014 Sep 19;14(Suppl 6):S5. [Crossref], [Google Scholar], [Publisher]
  2. Qiu J, Söderlund-Venermo M, Young NS. Human parvoviruses. Clinical microbiology reviews. 2017 Jan;30(1):43-113. [Crossref], [Google Scholar], [Publisher]
  3. Nasir IA, Yakubu SA, Mustapha JO. Epidemiology and synergistic hepatopathology of malaria and hepatitis C virus coinfection. Virology: Research and Treatment. 2017 Aug 3;8:1178122X17724411. [Crossref], [Google Scholar], [Publisher]
  4. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World journal of gastroenterology. 2016 Sep 9;22(34):7824. [Crossref], [Google Scholar], [Publisher]
  5. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2014 Dec 29;61(1):77-87. [Crossref], [Google Scholar], [Publisher]
  6. Zheng X, Pang M, Chan A, Roberto A, Warner D, Yen-Lieberman B. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods. Journal of Clinical Virology. 2003 Oct 1;28(2):214-6. [Crossref], [Google Scholar], [Publisher]
  7. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014 Jan;59(1):318-27. [Crossref], [Google Scholar], [Publisher]
  8. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, Pybus OG, Allain JP, Hatzakis A. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS medicine. 2009 Dec 15;6(12):e1000198. [Crossref], [Google Scholar], [Publisher]
  9. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, Syhavong B, Phetsouvanah R, Sheridan I, Humphreys IS, Lu L. Genetic history of hepatitis C virus in East Asia. Journal of virology. 2009 Jan 15;83(2):1071-82. [Crossref], [Google Scholar], [Publisher]
  10. World Health Organization. Global technical strategy for malaria 2016-2030. World Health Organization; 2015 Nov 4. [Google Scholar], [PDF]
  11. Ashley, E.A., Pyae Phyo, A., and Woodrow, C.J. (2018). Malaria. Lancet, Apr 21;391(10130):1608-1621.
  12. Rupani AB, Amarapurkar AD. Hepatic changes in fatal malaria: an emerging problem. Annals of Tropical Medicine & Parasitology. 2009 Mar 1;103(2):119-27. [Crossref], [Google Scholar], [Publisher]
  13. Ruiz J, Kouiavskaia D, Migliorini M, Robinson S, Saenko EL, Gorlatova N, Li D, Lawrence D, Hyman BT, Weisgraber KH, Strickland DK. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. Journal of lipid research. 2005 Aug 1;46(8):1721-31. [Crossref], [Google Scholar], [Publisher]
  14. Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, Chen H. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell research. 2014 Sep;24(9):1050-66. [Crossref], [Google Scholar], [Publisher]
  15. Lauer GM, Walker BD. Hepatitis C virus infection. New England journal of medicine. 2001 Jul 5;345(1):41-52. [Google Scholar], [Publisher]
  16. Razavi H, ElKhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, Kumar R. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013 Jun;57(6):2164-70. [Crossref], [Google Scholar], [Publisher]
  17. ABUBAKAR A. Studies on the abundance and distribution of Mosquitoes and prevalence of Malaria in Yabo Local Government Area of Sokoto State, Nigeria. [Google Scholar], [Publisher]
  18. Anand AC, Ramji C, Narula AS, Singh W. Malarial hepatitis: a heterogeneous syndrome?. The National medical journal of India. 1992 Mar 1;5(2):59-62. [Google Scholar], [Publisher]
  19. Bhalla A, Suri V. Malarial hepatopathy. Journal of postgraduate medicine. 2006 Oct 1;52(4):315-20. [Google Scholar], [Publisher]
  20. Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS medicine. 2012 Feb 21;9(2):e1001169. [Crossref], [Google Scholar], [Publisher]
  21. Alven S, Aderibigbe B. Combination therapy strategies for the treatment of malaria. Molecules. 2019 Oct 7;24(19):3601. [Crossref], [Google Scholar], [Publisher]
  22. Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, Carlton JM, Joshi H. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malaria journal. 2012 Dec;11:1-5. [Crossref], [Google Scholar], [Publisher]
  23. Kochar DK, Agarwal P, Kochar SK, Jain R, Rawat N, Pokharna RK, Kachhawa S, Srivastava T. Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. Qjm. 2003 Jul 1;96(7):505-12. [Crossref], [Google Scholar], [Publisher]
  24. Filli FB, Igbodor FO, Zhema E. Socio-economic determinants of yam post-harvest losses among farmers in Wukari local government area of Taraba State, Nigeria. Journal OfAgriculture and Food Sciences. 2019;7(8):215-21. [Crossref], [Google Scholar], [PDF]
  25. Imarenezor EP, Brown ST, Yakubu OE, Soken DC. Survey of hepatitis B and C among students of Federal University Wukari, Taraba State, Nigeria. International Research Journal of Medicine and Medical Sciences. 2016;4(3):31-7. [Google Scholar], [Publisher]
  26. Muñoz-Chimeno M, Valencia J, Rodriguez-Recio A, Cuevas G, Garcia-Lugo A, Manzano S, Rodriguez-Paredes V, Fernandez B, Morago L, Casado C, Avellón A. HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests. Scientific Reports. 2023 May 9;13(1):7554. [Crossref], [Google Scholar], [Publisher]
  27. Aernan PT, Sar TT, Torkula SH. Prevalence of Plasmodia and hepatitis B virus co-infection in blood donors at Bishop Murray Medical Centre, Makurdi, Benue State, Nigeria. Asian Pacific journal of tropical medicine. 2011 Mar 1;4(3):224-6. [Crossref], [Google Scholar], [Publisher]
  28. Sharif AA, Dabo NT, Getso MI. Prevalence of malaria and hepatitis B virus infection in febrile patients in Kano northwest Nigeria. International Journal of Current Research and Review. 2015 May 1;7(9):61. [Google Scholar]
  29. Sule WF, Okonko IO, Ebute AJ, Donbraye E, Fadeyi A, Udeze AO, Alli JA. Farming and Non-Farming Individuals Attending Grimard Catholic Hospital, Anyigba, Kogi State, Nigeria were Comparable in Hepatitis B Surface Antigen Seroprevalence. Current Research Journal of Biological Sciences. 2010 Jul 20;2(4):278-82. [Google Scholar], [Publisher]
  30. World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO Member States. [Google Scholar], [PDF]
  31. Hamza M, Samaila AA, Yakasai AM, Babashani M, Borodo MM, Habib AG. Prevalence of hepatitis B and C virus infections among HIV-infected patients in a tertiary hospital in North-Western Nigeria. Nigerian Journal of Basic and Clinical Sciences. 2013 Jul 1;10(2):76-81. [Crossref], [Google Scholar], [PDF]
  32. Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola M, Egwuenu-Oladejo A, Ajisegiri SW, Sha'aibu S, Musa BO, Gidado S. Seroprevalence of hepatitis B infection in Nigeria: A national survey. The American journal of tropical medicine and hygiene. 2016 Oct 10;95(4):902. [Crossref], [Google Scholar], [Publisher]
  33. Gobir Z, Tukur Z. Prevalence of malaria parasitemia using rapid diagnostic test among apparently healthy children in Kano, Nigeria. Journal of Medicine in the Tropics. 2014 Jan 1;16(1):1-4. [Crossref], [Google Scholar], [Publisher]
  34. Igwe NM, Joannes UO, Chukwuma OB, Chukwudi OR, Oliaemeka EP, Maryrose AU, Joseph A. Prevalence and parasite density of asymptomatic malaria parasitemia among unbooked paturients at Abakaliki, Nigeria. Journal of Basic and Clinical Reproductive Sciences. 2014;3(1):44-8. [Google Scholar], [Publisher]
  35. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. Journal of hepatology. 2006 Jan 1;44:S6-9. [Crossref], [Google Scholar], [Publisher]
  36. Okonko IO, Horsefall SJ, Okerentugba PO, Frank-Peterside N. HBV and HIV coinfections among intending blood donors in Port Harcourt, Nigeria. Journal of Immunoassay and immunochemistry. 2015 Jul 4;36(4):359-67. [Crossref], [Google Scholar], [Publisher]